Pharmacogenomics,volume 11,issue 8  (08-2010)

Period of time： 2010年8期

Publisher： Future Medicine

Founded in： 2000

Total resources： 113

ISSN： 1462-2416

Subject： R9 Pharmacy

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Pharmacogenomics,volume 11,issue 8

Menu

Cancer pharmacogenomics: do cancer cell lines have the right stuff?

By Auman J Todd in (2010)

Pharmacogenomics,volume 11,issue 8 , Vol. 11, Iss. 8, 2010-08 , pp. 1035-1037

Future Medicine

Abstract Access to resources Recommend Favorite

Complete genome sequencing and network modeling to overcome trastuzumab resistance

By Roukos Dimitrios H in (2010)

Pharmacogenomics,volume 11,issue 8 , Vol. 11, Iss. 8, 2010-08 , pp. 1039-1043

Future Medicine

Abstract Access to resources Recommend Favorite

News & Views in ... Pharmacogenomics

By in (2010)

Pharmacogenomics,volume 11,issue 8 , Vol. 11, Iss. 8, 2010-08 , pp. 1045-1047

Future Medicine

Abstract Access to resources Recommend Favorite

Research Highlights

By Spindler Karen-Lise Garm,Jakobsen Anders in (2010)

Pharmacogenomics,volume 11,issue 8 , Vol. 11, Iss. 8, 2010-08 , pp. 1049-1052

Future Medicine

Abstract Access to resources Recommend Favorite

Genetic variation in three candidate genes and nicotine dependence, withdrawal and smoking cessation in hospitalized patients

By De Ruyck Kim,Nackaerts Kristiaan,Beels Laurence,Werbrouck Joke,De Volder Annick,Meysman Marc,Salhi Bihiyga,Van Meerbeeck Jan,Thierens Hubert in (2010)

Pharmacogenomics,volume 11,issue 8 , Vol. 11, Iss. 8, 2010-08 , pp. 1053-1063

Future Medicine

Abstract Access to resources Recommend Favorite

Pharmacogenetic interactions between ABCB1 and SLCO1B1 tagging SNPs and the effectiveness of statins in the prevention of myocardial infarction

By Peters Bas JM,Rodin Andrei S,Klungel Olaf H,van Duijn Cornelia M,Stricker Bruno H Ch,Slot Ruben van’t,de Boer Anthonius,Maitland-van der Zee Anke-Hilse in (2010)

Pharmacogenomics,volume 11,issue 8 , Vol. 11, Iss. 8, 2010-08 , pp. 1065-1076

Future Medicine

Abstract Access to resources Recommend Favorite

Interethnic comparisons of important pharmacology genes using SNP databases: potential application to drug regulatory assessments

By Chen Jieming,Teo Yik Ying,Toh Dorothy SL,Sung Cynthia in (2010)

Pharmacogenomics,volume 11,issue 8 , Vol. 11, Iss. 8, 2010-08 , pp. 1077-1094

Future Medicine

Abstract Access to resources Recommend Favorite

Characterization of the genetic profile of CYP2C19 in two South African populations

By Drögemöller Britt I,Wright Galen EB,Niehaus Dana JH,Koen Liezl,Malan Stefanie,Da Silva Danielle M,Hillermann–Rebello Renate,La Grange Anthony M,Venter Mauritz,Warnich Louise in (2010)

Pharmacogenomics,volume 11,issue 8 , Vol. 11, Iss. 8, 2010-08 , pp. 1095-1103

Future Medicine

Abstract Access to resources Recommend Favorite

CUL2 and STK11 as novel response-predictive genes for neoadjuvant radiochemotherapy in esophageal cancer

By Metzger Ralf,Heukamp Lukas,Drebber Uta,Bollschweiler Elfriede,Zander Thomas,Hoelscher Arnulf H,Warnecke-Eberz Ute in (2010)

Pharmacogenomics,volume 11,issue 8 , Vol. 11, Iss. 8, 2010-08 , pp. 1105-1113

Future Medicine

Abstract Access to resources Recommend Favorite

Tailored therapy of ACE inhibitors in stable coronary artery disease: pharmacogenetic profiling of treatment benefit

By Brugts Jasper J,Boersma Eric,Simoons Maarten L in (2010)

Pharmacogenomics,volume 11,issue 8 , Vol. 11, Iss. 8, 2010-08 , pp. 1115-1126

Future Medicine

Abstract Access to resources Recommend Favorite

Previous 1 2 Next Display item(s) per page Total 16 item(s)